CA3

General Information


DRACP ID  DRACP05523

Peptide Name   CA3

Sequence  XACRGRGRGCGSGSGSCG

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  All cysteines form disulfide bridges with the T3-scaffold.

N-terminal Modification  FITC

C-terminal Modification  Amidation

Other Modification  X=Ahx, 6-aminohexanoic acid

Chiral  L



Physicochemical Information


Formula  C53H92N26O20S3

Absent amino acids  DEFHIKLMNPQTVWY

Common amino acids  G

Mass  192306

Pl  9

Basic residues  3

Acidic residues  0

Hydrophobic residues  1

Net charge  3

Boman Index  -4273

Hydrophobicity  -52.22

Aliphatic Index  5.56

Half Life 
  /

Extinction Coefficient cystines  125

Absorbance 280nm  7.35

Polar residues  13

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24697151

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2365

DRACP is developed by Dr.Zheng's team.